Clinical Trials Directory

Trials / Sponsors / Incyte Biosciences International Sàrl

Incyte Biosciences International Sàrl

Industry · 10 registered clinical trials — 1 currently recruiting.

StatusTrialPhaseStarted
WithdrawnINCAGN01876 in Combination With Immunotherapy in Participants With Recurrent or Metastatic Head and Neck Squam
Metastatic Head and Neck Squamous Cell Carcinoma, Advanced Malignancies, Recurrent Head and Neck Squamous Cell Carcinoma
Phase 22023-03-01
Active Not RecruitingStudy of Retinfanlimab in Combination With INCAGN02385 and INCAGN02390 as First-Line Treatment in Participants
Head and Neck Cancer
Phase 22022-11-14
RecruitingSafety and Efficacy of Ponatinib for Treatment of Pediatric Recurrent or Refractory Leukemias, Lymphomas or So
Acute Myeloid Leukemia, Accelerated Phase Chronic Myeloid Leukemia, Blast Phase Chronic Myeloid Leukemia
Phase 1 / Phase 22020-01-29
WithdrawnA Study to Evaluate Effectiveness and Safety of Ponatinib in Patients With BCR-ABL Positive ALL in Standard Cl
BCR-ABL Positive Acute Lymphoblastic Leukemia
—2018-12-31
CompletedA Safety and Tolerability Study of INCAGN02385 in Select Advanced Malignancies
Cervical Cancer, Microsatellite Instability (MSI)-High Endometrial Cancer, Gastric Cancer (Including Stomach and Gastroesophageal Junction [GEJ])
Phase 12018-06-18
TerminatedINCAGN01876 in Combination With Immune Therapies in Subjects With Advanced or Metastatic Malignancies
Advanced Malignancies, Metastatic Cancer
Phase 1 / Phase 22017-11-21
CompletedA Study Exploring the Safety and Efficacy of INCAGN01949 in Combination With Immune Therapies in Advanced or M
Advanced Malignancies
Phase 1 / Phase 22017-10-09
CompletedPhase 1/2 Study Exploring the Safety, Tolerability, and Efficacy of INCAGN01876 Combined With Immune Therapies
Advanced Malignancies, Metastatic Cancer
Phase 1 / Phase 22017-04-25
CompletedA Phase 1/2, Open-Label, Dose-Escalation, Safety Study of INCAGN01949 in Subjects With Advanced or Metastatic
Advanced Malignancies, Metastatic Cancer
Phase 1 / Phase 22016-10-31
CompletedA Study of INCAGN01876 in Participants With Advanced or Metastatic Solid Tumors
Advanced Malignancies, Metastatic Cancer
Phase 1 / Phase 22016-06-20